Enasidenib

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 250 publications

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions.

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions.

Journal: Journal of personalized medicine

Published: February 16, 2026

Management of Acute Myeloid Leukemia: A Review.

Management of Acute Myeloid Leukemia: A Review.

Journal: Cancers

Published: January 13, 2026

Differentiation Syndrome in Acute Myeloid Leukemia: Molecular Mechanisms, Clinical Spectrum, and Emerging Therapeutic Paradigms.

Differentiation Syndrome in Acute Myeloid Leukemia: Molecular Mechanisms, Clinical Spectrum, and Emerging Therapeutic Paradigms.

Journal: International journal of molecular sciences

Published: December 29, 2025

The Care and Cure of the Leukemias in 2026.

The Care and Cure of the Leukemias in 2026.

Journal: American journal of hematology

Published: December 03, 2025

Νοvel Therapies in High-Risk Myelodysplastic Syndromes.

Νοvel Therapies in High-Risk Myelodysplastic Syndromes.

Journal: European journal of haematology

Published: November 23, 2025

Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukemia.

Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukemia.

Journal: Chemistry & biodiversity

Published: October 08, 2025

Green Ultra-Fast UPLC-MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability.

Green Ultra-Fast UPLC-MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability.

Journal: Biomedical chromatography : BMC

Published: September 27, 2025

Development and Validation of a Simultaneous Quantification Method for 12 Targeted Therapies and 3 Active Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry: An Application to Therapeutic Drug Monitoring in Patients With Hematological Malignancies.

Development and Validation of a Simultaneous Quantification Method for 12 Targeted Therapies and 3 Active Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry: An Application to Therapeutic Drug Monitoring in Patients With Hematological Malignancies.

Journal: Therapeutic drug monitoring

Published: September 15, 2025

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors.

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors.

Journal: Frontiers in pharmacology

Published: August 31, 2025

Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.

Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.

Journal: Current treatment options in oncology

Published: July 30, 2025

Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors.

Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors.

Journal: Blood neoplasia

Published: July 28, 2025

Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia.

Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia.

Journal: Transplantation and cellular therapy

Published: July 28, 2025

Showing 1-12 of 250

Last Updated: 04/28/2026